The relationship between exocrine pancreatic function and plasma pancreatic polypeptide levels was studied in 14 normal elderly subjects and in ten elderly patients with exocrine pancreatic insufficiency determined by the para -aminobenzoic acid test. There was a decrease in the total pancreatic polypeptide response after a standard mixed meal in the group with pancreatic insufficiency (t = 2 -753, p = 0* 01). An increase above basal of less than 100% in plasma pancreatic polypeptide levels 30 min after a standard mLxed meal is strongly associated with exocrine pancreatic insufficiency (Fisher's exact test, p = 0 * 005). INTRODUCTION The para -aminobenzoic acid test is a standard non -invasive test for exocrine pancreatic insufficiency. Its high sensitivity and specificity in identifying cases of severe exocrine pancreatic insufficiency merit its use as a screening tool, although it is less accurate for moderate cases.1 Elderly people have difficulty coping with this test, and a simpler, equally reliable, initial screening test for exocrine pancreatic insufficiency would be welcome. Plasma levels of pancreatic polypeptide are related to exocrine pancreatic function in both normal and diseased states.2-4 Pancreatic polypeptide, a 36 amino acid peptide, inhibits exocrine pancreatic secretion.5 In healthy adults (aged 18-46 years) plasma pancreatic polypeptide levels following nutrient and hormonal stimulation are closely related to exocrine pancreatic function.4 Stimulated levels of pancreatic polypeptide are reduced in exocrine pancreatic insufficiency.3 This suggests that plasma pancreatic polypeptide measurement may be a useful screening test for exocrine pancreatic insufficiency.6 It is not known whether such a relationship between pancreatic polypeptide secretion and exocrine pancreatic function also exists in the elderly. If it did, plasma pancreatic polypeptide levels
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The para -aminobenzoic acid test is a standard non -invasive test for exocrine pancreatic insufficiency. Its high sensitivity and specificity in identifying cases of severe exocrine pancreatic insufficiency merit its use as a screening tool, although it is less accurate for moderate cases.1 Elderly people have difficulty coping with this test, and a simpler, equally reliable, initial screening test for exocrine pancreatic insufficiency would be welcome. Plasma levels of pancreatic polypeptide are related to exocrine pancreatic function in both normal and diseased states.2-4 Pancreatic polypeptide, a 36 amino acid peptide, inhibits exocrine pancreatic secretion. 5 In healthy adults (aged 18-46 years) plasma pancreatic polypeptide levels following nutrient and hormonal stimulation are closely related to exocrine pancreatic function.4 Stimulated levels of pancreatic polypeptide are reduced in exocrine pancreatic insufficiency.3 This suggests that plasma pancreatic polypeptide measurement may be a useful screening test for exocrine pancreatic insufficiency.6 It is not known whether such a relationship between pancreatic polypeptide secretion and exocrine pancreatic function also exists in the elderly. If it did, plasma pancreatic polypeptide levels after a standard mixed meal could be used as a screening test before proceeding to para -aminobenzoic acid or more invasive testing. The present study investigated the relationship between the plasma pancreatic polypeptide response to a standard mixed meal in elderly subjects with normal and abnormal para -aminobenzoic acid (PABA) tests.
SUBJECTS AND METHODS
Fourteen elderly subjects (group 1), mean (± SE) age 74 -7 ± 1 -4 years with normal para -aminobenzoic acid (PABA) tests, and five asymptomatic subjects (group 2), with a para -aminobenzoic acid excretion index of less than 55% were recruited from a previous study. In that study a sample of 21 healthy subjects, over the age of 65 years and living independently in the community, were screened for evidence of pancreatic insufficiency by para -aminobenzoic acid testing. Those with significant hepatic or renal disease or a history of gastrointestinal surgery, alcohol excess or diabetes mellitus were excluded from the study.7 Five additional subjects, aged over 60 years, with moderate to severe exocrine pancreatic insufficiency (para -aminobenzoic acid excretion index less than 55% and symptoms/signs of malabsorption) diagnosed in the previous 12 months and studied pre-treatment were also included in group 2. The mean age of the ten patients in group 2 was 68-5 ± 1 -5 years. The modified para -aminobenzoic acid test8 consists of two stages. On day 1, after overnight fasting, N -benzoyl -1-tryosyl -para -aminobenzoic acid is given along with a standard mixed meal of 50 g of carbohydrate, 18 g of protein and 20 g of fat and the urine is collected over the next 6 hours. N -benzoyl -1 -tryoslpara -aminobenzoic acid requires pancreatic chymotrypsin to liberate paraaminobenzoic acid which is then absorbed and excreted in the urine. On day 2 the procedure is repeated with para -aminobenzoic acid to exclude causes of malabsorption other than pancreatic insufficiency. The para -aminobenzoic acid excretion index is then calculated as the percentage of day 1 /day 2 urinary paraaminobenzoic acid excretion, a figure of less than 55 % indicating exocrine pancreatic insufficiency. To ensure that all urine was collected, a named nurse accompanied each patient throughout each 6 hour period, a single toilet was set apart for each subject and urine was collected using a urinal. Blood samples for insulin and pancreatic polypeptide levels were taken at -15, 0, 15, 30, 60, 90 and 120 min following ingestion of a standard mixed meal. The samples were centrifuged and plasma was stored at -20 IC until the study had been completed. The hormones were measured by radioimmunoassay.9 Statistical analysis: The unpaired t -test was used to compare the area under the curve and individual results for the log transformation of pancreatic polypeptide and insulin responses over the first hour (which covers the initial rise in plasma pancreatic polypeptide) after a standard mixed meal between groups 1 and 2. (The log transformation was applied to the data as the response for pancreatic polypeptide and insulin over time was skewed). Fisher's exact test was used to examine the association between para -aminobenzoic acid testing and the percentage rise in plasma pancreatic polypeptide levels at 30 minutes after a standard mixed meal compared with basal (-15 min) plasma pancreatic polypeptide levels (a rise of less than 100 % was taken as indicating abnormal exocrine pancreatic function). minutes after a standard mixed meal) plasma pancreatic polypeptide and insulin levels were compared between groups 1 and 2 (Fig 1) . The basal pancreatic polypeptidelevels(mean SE)were 99 9 18*5 pg/mland 69*5 17-pg/ml, respectively. The total area under the curve for log pancreatic polypeptide and log insulin responses over time was significantly less in group 2 (pancreatic polypeptide p = 0-01, insulin p=0 -007). The log pancreatic polypeptide and log insulin levels in group 2 at 15, 30, and 60 min after the standard mixed meal were also significantly less compared with group 1. If the 30 minute plasma pancreatic polypeptide level was less than 100 % greater than fasting, the patient very probably had an abnormal para -aminobenzoic acid test (Fisher's exact test p= 0 005). (Fig 2) . This reduced pancreatic polypeptide response in the elderly subjects with exocrine pancreatic insufficiency agrees with studies in younger subjects.2-4 In this study, a strong association was found between a rise in plasma pancreatic polypeptide levels at 30 min of less than 100% and the presence of exocrine pancreatic insufficiency as determined by para -aminobenzoic acid testing, which may prove to be a simpler screening test for exocrine pancreatic insufficiency in the elderly. Para -aminobenzoic acid testing cannot be used to quantify the degree of exocrine pancreatic insufficiency, but it does help to differentiate patients with moderate to severe pancreatic insufficiency from those with normal exocrine pancreatic function or only mild impairment." 19 A similar limitation may also apply to pancreatic polypeptide measurement for assessing exocrine pancreatic function.4
